Encompass Health Corporation Forecast, price target & analysts
Encompass Health Corporation Target price 2025 - Analyst rating & recommendation
Encompass Health Corporation Classifications & Recommendation:
Encompass Health Corporation Price Target
| Target Price | $117.25 |
| Price | $96.71 |
| Potential |
21.24%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Encompass Health Corporation 2026 .
The average Encompass Health Corporation target price is $117.25.
This is
21.24%
register free of charge
$125.00
29.25%
register free of charge
$110.00
13.74%
register free of charge
|
|
| A rating was issued by 14 analysts: 13 Analysts recommend Encompass Health Corporation to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Encompass Health Corporation stock has an average upside potential 2026 of
21.24%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 5.37 | 5.85 |
| 11.91% | 8.92% | |
| EBITDA Margin | 21.66% | 20.27% |
| 3.43% | 6.44% | |
| Net Margin | 8.37% | 8.62% |
| 14.85% | 3.05% |
12 Analysts have issued a sales forecast Encompass Health Corporation 2025 . The average Encompass Health Corporation sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Encompass Health Corporation EBITDA forecast 2025. The average Encompass Health Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Encompass Health Corporation Analysts have issued a net profit forecast 2025. The average Encompass Health Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 4.46 | 5.00 |
| 28.53% | 12.11% | |
| P/E | 19.33 | |
| EV/Sales | 2.24 |
7 Analysts have issued a Encompass Health Corporation forecast for earnings per share. The average Encompass Health Corporation EPS is
This results in the following potential growth metrics and future valuations:
Encompass Health Corporation...
Current Encompass Health Corporation Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Feb 11 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Feb 10 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Feb 07 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Oct 30 2024 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Oct 30 2024 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 29 2024 |
| Keybanc |
Locked
➜
Locked
|
Locked | Oct 29 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Feb 11 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Feb 10 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Feb 07 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Oct 30 2024 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Oct 30 2024 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 29 2024 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Oct 29 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
